0001493152-18-008649.txt : 20180613 0001493152-18-008649.hdr.sgml : 20180613 20180613215529 ACCESSION NUMBER: 0001493152-18-008649 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180611 FILED AS OF DATE: 20180613 DATE AS OF CHANGE: 20180613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Urdea Michael S CENTRAL INDEX KEY: 0001569434 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38185 FILM NUMBER: 18897990 MAIL ADDRESS: STREET 1: 100 BUNCE MEADOWS DRIVE CITY: ALAMO STATE: CA ZIP: 94507 FORMER NAME: FORMER CONFORMED NAME: Urdea michael S DATE OF NAME CHANGE: 20130211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 BUSINESS PHONE: 5082301828 MAIL ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON BIOMEDICA INC DATE OF NAME CHANGE: 19960812 4 1 form4.xml X0306 4 2018-06-11 0 0000830656 PRESSURE BIOSCIENCES INC PBIO 0001569434 Urdea Michael S 100 BOUNCE MEADOWS DRIVE ALAMO CA 94507 1 0 0 0 SERIES AA CONVERTIBLE PREFERRED STOCK 2.50 2018-06-11 4 J 0 20.2 2500 A 2018-06-11 2019-06-11 COMMON STOCK 20200 20.2 D COMMON STOCK WARRANT 3.50 2018-06-11 4 J 0 20200 A 2018-06-11 2023-06-11 COMMON STOCK 20200 20200 D COMMON STOCK WARRANT 3.50 2018-06-11 4 J 0 2739 A 2016-03-31 2021-03-31 COMMON STOCK 2739 2739 D On June 11, 2018, Pressure BioSciences, Inc. (the "Issuer") entered into a letter agreement with Mr. Urdea (the "Reporting Person"). The Reporting Person previously held a convertible debenture with a face value of $50,600 (the "Debenture") and warrants to purchase common stock (the "Debenture Warrants"). Pursuant to the letter agreement, the Reporting Person agreed to convert the principal due to him pursuant to the Debenture into shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share. The Reporting Person was also: (a) issued amended Debenture Warrants (originally issued on March 31, 2016) such that the exercise price is now $3.50 per share; and (b) issued a new warrant with an exercise price of $3.50 per share to purchase such number of shares of common stock as equal 100% of the number of shares of common stock issuable upon conversion of the Series AA Convertible Preferred Stock shares received as a result of the Debenture conversion. /s/ Michael S Urdea 2018-06-13